Reply
- PMID: 31146948
- DOI: 10.1016/j.jcrs.2019.03.027
Reply
Comment on
-
Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: Randomized controlled clinical trial.J Cataract Refract Surg. 2019 Mar;45(3):343-350. doi: 10.1016/j.jcrs.2018.10.044. Epub 2019 Jan 25. J Cataract Refract Surg. 2019. PMID: 30691922 Clinical Trial.
-
One-sided versus 2-sided statistical analysis of the safety and efficacy of intracameral moxifloxacin to prevent post-cataract endophthalmitis.J Cataract Refract Surg. 2019 Jun;45(6):890. doi: 10.1016/j.jcrs.2019.03.026. J Cataract Refract Surg. 2019. PMID: 31146949 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical